Donald Ingber

Donald Ingber

Donald Ingber


Donald E. Ingber, M.D., Ph.D., is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He received his B.A., M.A., M.Phil., M.D. and Ph.D. from Yale University.

Donald Ingber is a pioneer in the field of biologically inspired engineering, and at the Wyss Institute, he currently leads a multifaceted effort to develop breakthrough bioinspired technologies to advance healthcare and to improve sustainability. His work has led to major advances in mechanobiology, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology and translational medicine. Through his work, Ingber also has helped to break down boundaries between science, art and design.

Donald Ingber has authored more than 425 publications and 150 patents, founded 5 companies, and been a guest speaker at more than 475 events internationally. He is a member of the National Academy of Medicine, National Academy of Inventors, American Institute for Medical and Biological Engineering, and the American Academy of Arts and Sciences. He was named one of the Top 20 Translational Researchers world-wide in 2012 (Nature Biotechnology), and a Leading Global Thinker of 2015 (Foreign Policy magazine).

Some of Donald Ingber’s most recently developed technologies include an anticoagulant surface coating for medical devices that replaces the need for dangerous blood-thinning drugs; a dialysis-like sepsis therapeutic device that clears blood of pathogens and inflammatory toxins; a shear stress-activated nanotherapeutic that targets clot-busting drugs to sites of vascular occlusion; and Human Organs-on-Chips created with microchip manufacturing methods and lined by living human cells, which are being used to replace animal testing as a more accurate and affordable in vitro platform for drug development and personalized medicine. In 2015, Ingber’s Organs-on-Chips technology was named Design of the Year by the London Design Museum and was also acquired by the Museum of Modern Art (MoMA) in New York City for its permanent design collection. His Organs-on-Chips were also named one of the Top 10 Emerging Technologies of 2016 by the World Economic Forum.


B.A., M.A. and M.Phil. from Yale University

M.D. and Ph.D. from Yale University

Awards, Honors, and Distinctions:

2014: Delivered the Graeme Clark Oration in Melbourne, Australia to an audience of over 1,400

2013: Received the NC3Rs 3Rs Prize from the UK’s National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and was named an honorary member of the Society of Toxicology for his work on Organs-on-Chips.

2012: Elected to the Institute of Medicine (IOM) of the U.S. National Academies, one of the highest honors in the field of medicine in the United States and won the World Technology Award in the biotechnology category.

2011, Inducted into the American Institute for Medical and Biological Engineering’s College of Fellows and received the Holst Medal.

2010: Received the Lifetime Achievement Award from the Society for In Vitro Biology and the Rous-Whipple Award from the American Society for Investigative Pathology.

2009: Received the Pritzker Award from the Biomedical Engineering Society.

2009-2014: Received a Breast Cancer Innovator Award from the Department of Defense.

2005: Received the Talbot Medal in Theoretical and Applied Mechanics.

2002: he was named to Esquire’s list of the world’s “Best and Brightest”.

1991 to 1996: Recipient of an American Cancer Society Faculty Research Award

Representative Publications:

Donald Ingber has authored more than 425 publications

Wyss Institut

Wyss Institut

This is a unique website which will require a more modern browser to work! Please upgrade today!

Social Media Auto Publish Powered By :